356 related articles for article (PubMed ID: 19411782)
21. The Clinical Relevance of Anti-DFS70 Autoantibodies.
Conrad K; Röber N; Andrade LE; Mahler M
Clin Rev Allergy Immunol; 2017 Apr; 52(2):202-216. PubMed ID: 27350273
[TBL] [Abstract][Full Text] [Related]
22. High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease.
Muro Y; Sugiura K; Morita Y; Tomita Y
Lupus; 2008 Mar; 17(3):171-6. PubMed ID: 18372356
[TBL] [Abstract][Full Text] [Related]
23. The importance of detecting anti-DFS70 in routine clinical practice: comparison of different care settings.
Bonroy C; Schouwers S; Berth M; Stubbe M; Piette Y; Hoffman I; Devreese K; Van Hoovels L
Clin Chem Lab Med; 2018 Jun; 56(7):1090-1099. PubMed ID: 29427547
[TBL] [Abstract][Full Text] [Related]
24. Clinical value of anti-DFS70 antibodies in a cohort of patients undergoing routine antinuclear antibodies testing.
Yumuk Z; Demir M
J Immunol Methods; 2020 May; 480():112754. PubMed ID: 32057435
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of anti-dense fine speckled 70 antibodies in healthy individuals and patients with antinuclear antibody-associated autoimmune rheumatic diseases in Japan.
Hayashi N; Uto K; Imanishi A; Sugiyama D; Morinobu A; Saegusa J
Medicine (Baltimore); 2021 Mar; 100(9):e24556. PubMed ID: 33655922
[TBL] [Abstract][Full Text] [Related]
26. Autoantibodies to Dense Fine Speckles in Pediatric Diseases and Controls.
Schmeling H; Mahler M; Levy DM; Moore K; Stevens AM; Wick J; McMillan JD; Horneff G; Assassi S; Charles J; Salazar G; Mayes MD; Silverman ED; Klien-Gitelman M; Lee T; Brunner HI; Reed AM; Fritzler MJ
J Rheumatol; 2015 Dec; 42(12):2419-26. PubMed ID: 26472409
[TBL] [Abstract][Full Text] [Related]
27. Antibodies to the lens and cornea in anti-DFS70-positive subjects.
Bizzaro N; Tonutti E; Visentini D; Alessio MG; Platzgummer S; Morozzi G; Antico A; Villalta D; Piller-Roner S; Vigevani E
Ann N Y Acad Sci; 2007 Jun; 1107():174-83. PubMed ID: 17804545
[TBL] [Abstract][Full Text] [Related]
28. Anti-DFS70 antibodies: a useful biomarker in a pediatric case with suspected autoimmune disease.
Fabris M; Zago S; Tosolini R; Melli P; Bizzaro N; Tonutti E
Pediatrics; 2014 Dec; 134(6):e1706-8. PubMed ID: 25384487
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases.
Marin GG; Cardiel MH; Cornejo H; Viveros ME
J Clin Rheumatol; 2009 Oct; 15(7):325-9. PubMed ID: 20009966
[TBL] [Abstract][Full Text] [Related]
30. A novel magnetic bead-based immunoprecipitation method for anti-dense fine speckled 70 antibodies.
Chen R; Wei X; Yang C; Nguyen K
Pathology; 2023 Oct; 55(6):843-849. PubMed ID: 37336684
[TBL] [Abstract][Full Text] [Related]
31. Anti-DFS70 antibodies in 597 healthy hospital workers.
Watanabe A; Kodera M; Sugiura K; Usuda T; Tan EM; Takasaki Y; Tomita Y; Muro Y
Arthritis Rheum; 2004 Mar; 50(3):892-900. PubMed ID: 15022332
[TBL] [Abstract][Full Text] [Related]
32. The significance of dense fine speckled pattern in antinuclear antibody-associated rheumatic disease and coexisting autoantibodies: A propensity score-matched cohort study.
Cheng CF; Lan TY; Kao JH; Lu CH; Chang YC; Huang YM; Yang FJ; Chen JH; Lin YC; Chuang CA; Chang CH; Li KJ; Shen CY; Hsieh SC
Int J Rheum Dis; 2023 Sep; 26(9):1667-1675. PubMed ID: 37338084
[TBL] [Abstract][Full Text] [Related]
33. New genetically engineered DFS70 knock-out HEp-2 cells enable rapid and specific recognition of anti-DFS70 antibodies.
Bizzaro N; Fabris M
Autoimmunity; 2018 Jun; 51(4):152-156. PubMed ID: 29732925
[TBL] [Abstract][Full Text] [Related]
34. [Investigation of the Clinical Significance of Anti-Dense Fine Speckled 70 (anti-DFS70) Autoantibody and Determination of Accompanying Pathologies].
Çetin Duran A; Barut K; Duran A; Eren Dağlar D
Mikrobiyol Bul; 2021 Jul; 55(3):415-425. PubMed ID: 34416806
[TBL] [Abstract][Full Text] [Related]
35. High Sensitivity Detection of Anti-DFS70 Antibodies by Radioimmunoprecipitation Assay (RIPA).
Seelig CA; Blüthner M; Seelig HP
Clin Lab; 2020 May; 66(5):. PubMed ID: 32390377
[TBL] [Abstract][Full Text] [Related]
36. The clinical impact of Anti-DFS70 antibodies in undifferentiated connective tissue disease: case reports and a review of the literature.
Infantino M; Meacci F; Grossi V; Manfredi M; Li Gobbi F; Sarzi-Puttini P; Atzeni F; Benucci M
Immunol Res; 2017 Feb; 65(1):293-295. PubMed ID: 27427300
[TBL] [Abstract][Full Text] [Related]
37. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.
Mariz HA; Sato EI; Barbosa SH; Rodrigues SH; Dellavance A; Andrade LE
Arthritis Rheum; 2011 Jan; 63(1):191-200. PubMed ID: 20954189
[TBL] [Abstract][Full Text] [Related]
38. Positivity for antinuclear antibody in patients with advanced rheumatoid arthritis.
Nishimura S; Nishiya K; Hisakawa N; Chikazawa H; Ookubo S; Nakatani K; Hashimoto K
Acta Med Okayama; 1996 Oct; 50(5):261-5. PubMed ID: 8914679
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate.
Malyavantham KS; Suresh L
J Vis Exp; 2018 Jan; (131):. PubMed ID: 29364249
[TBL] [Abstract][Full Text] [Related]
40. Investigation of anti-DFS70 antibody in patients with systemic autoimmune rheumatic diseases.
Peker BO; Şener AG; Tarhan EF; Kaya S
Clin Rheumatol; 2019 Dec; 38(12):3627-3633. PubMed ID: 31396837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
